Answers are grounded in this paper and cite their sources.
The study of protein misfolding and aggregation has been a breakthrough in the realm of protein biochemistry. Protein aggregation is believed to be an intrinsic property of the polypeptide chain linked to its common peptide backbone. Aggregation of certain proteins into inclusion bodies or plaques is linked to a number of neurodegenerative diseases, including Parkinson’s, Alzheimer’s, and Huntington’s disease. Theophylline is a methylxanthine derivative, commonly found in tea, cocoa beans, and chocolates. In the present study, we have reported that theophylline acts as an inhibitor of haemoglobin (Hb) aggregation. The conformational changes in Hb were studied using turbidity assay, intrinsic fluorescence, Congo red assay, thioflavin-T (ThT) assay, Soret spectroscopy, Rayleigh scattering, and circular dichroism. The rise in ThT fluorescence and Congo red absorbance, concomitant with the 11 nm red shift, validates the formation of Hb aggregated at elevated temperature. These results were further confirmed by the loss of negative minima at 208 and 222 nm, which is a hallmark of α-helix. Hb was further incubated with theophylline taken in increasing concentrations at 70°C for 4 h. The decrease in ThT, Rayleigh, and intrinsic fluorescence, turbidity, Soret, and Congo red absorbance suggested the preventive effect of theophylline in a dose-dependent manner. Inhibitory activity of theophylline against the Hb aggregation may guide us in designing novel therapeutic drugs linked to protein aggregation diseases.
No takes yet. Share an insight, caveat, or question.
Ansari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: